Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of immune checkpoint inhibitors in different types of melanoma.
Rossi E, Schinzari G, Maiorano BA, Indellicati G, Di Stefani A, Pagliara MM, Fragomeni SM, De Luca EV, Sammarco MG, Garganese G, Galli J, Blasi MA, Paludetti G, Scambia G, Peris K, Tortora G. Rossi E, et al. Among authors: scambia g. Hum Vaccin Immunother. 2021 Jan 2;17(1):4-13. doi: 10.1080/21645515.2020.1771986. Epub 2020 Jul 14. Hum Vaccin Immunother. 2021. PMID: 32663057 Free PMC article.
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer.
Lorusso D, Ceni V, Muratore M, Salutari V, Nero C, Pietragalla A, Ciccarone F, Carbone V, Daniele G, Scambia G. Lorusso D, et al. Among authors: scambia g. Expert Opin Emerg Drugs. 2020 Dec;25(4):445-453. doi: 10.1080/14728214.2020.1836155. Epub 2020 Oct 20. Expert Opin Emerg Drugs. 2020. PMID: 33040627 Review.
Pembrolizumab for advanced cervical cancer: safety and efficacy.
De Felice F, Giudice E, Bolomini G, Distefano MG, Scambia G, Fagotti A, Marchetti C. De Felice F, et al. Among authors: scambia g. Expert Rev Anticancer Ther. 2021 Feb;21(2):221-228. doi: 10.1080/14737140.2021.1850279. Epub 2020 Nov 26. Expert Rev Anticancer Ther. 2021. PMID: 33183120 Review.
Immunotherapy in gynecological cancers.
Lorusso D, Ceni V, Daniele G, Pietragalla A, Salutari V, Muratore M, Nero C, Ciccarone F, Scambia G. Lorusso D, et al. Among authors: scambia g. Explor Target Antitumor Ther. 2021;2(1):48-64. doi: 10.37349/etat.2021.00033. Epub 2021 Feb 28. Explor Target Antitumor Ther. 2021. PMID: 36046088 Free PMC article. Review.
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
Imterat M, Bizzarri N, Fruscio R, Perrone AM, Traut A, du Bois A, Rosati A, Ferrari D, De Iaco P, Ataseven B, Ergasti R, Volontè S, Tesei M, Heitz F, Perri MT, Concin N, Fanfani F, Scambia G, Fagotti A, Harter P. Imterat M, et al. Among authors: scambia g. Int J Gynecol Cancer. 2023 Jan 3;33(1):42-49. doi: 10.1136/ijgc-2022-003745. Int J Gynecol Cancer. 2023. PMID: 36104079
Preoperative Tumor Texture Analysis on MRI for High-Risk Disease Prediction in Endometrial Cancer: A Hypothesis-Generating Study.
Miccò M, Gui B, Russo L, Boldrini L, Lenkowicz J, Cicogna S, Cosentino F, Restaino G, Avesani G, Panico C, Moro F, Ciccarone F, Macchia G, Valentini V, Scambia G, Manfredi R, Fanfani F. Miccò M, et al. Among authors: scambia g. J Pers Med. 2022 Nov 7;12(11):1854. doi: 10.3390/jpm12111854. J Pers Med. 2022. PMID: 36579601 Free PMC article.
1,968 results